Ting Yang

Ms. Ting Yang

orcid

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 April 2024 in hLife
Verified
Journal Article
Open access
xiangping lixiangping li
xiangping li
MWMengge Wang
Mengge Wang
HSHaoran Su
Haoran Su
SDShuhan Duan
Shuhan Duan
YSYuntao Sun
Yuntao Sun
GHGuanglin He
Guanglin He

29 May 2019 in Ophthalmic Research
Verified
Journal Article
Open access
PDF file
MJMinShan Jiang
MinShan Jiang
XXXiao-Li Xu
Xiao-Li Xu
TYTing Yang
Ting Yang
FLFeng Li
Feng Li
XZXuedian Zhang
Xuedian Zhang
Purpose: To compare the choroidal thickness (CT) measured by enhanced depth imaging optical coherence tomography (EDI-OCT) in preeclamptic, healthy pregnant, and healthy nonpregnant women. Methods: Studies that focused on the CT evaluation of pregnant women were retrieved by searching PubMed, Embase, Ovid, Cochrane, and Web of Science. We used Stata 14.0 SE for the meta-analysis and presented the results as the weighted mean difference (WMD) with a corresponding 95% CI. Results: A total of 14 studies with 1,227 participants were included in our meta-analysis. The CT of the healthy pregnancies (μm, WMD = 34.19, 95% CI: 20.63–47.76) was significantly higher than that of the nonpregnancies (Test of WMD = 0: z = 4.94, p = 0.000), but the CT of the preeclampsia (μm, WMD = 54.30, 95% CI: –13.40 to 122.01) was not significantly different from the nonpregnancies (Test of WMD = 0: z = 1.57, p = 0.116). In the preeclampsia versus healthy pregnancy group, 3 studies found that the choroid was thinner with preeclampsia, only one study found the CT increased. Conclusions: This meta-analysis suggested that the CT of the healthy pregnant women was significantly higher than that of the nonpregnant women. The presence of preeclampsia might complicate this situation. Most studies found that the CT decreased in the preeclamptic patients because of the increases in the systemic vasospasm and the blood pressure, which led to no significant difference compared with the nonpregnant women.

15 July 2021 in Journal of Clinical Nursing
Verified
Journal Article
Closed access
PDF file
TYTing Yang
Ting Yang
SWShurui Wang
Shurui Wang
XZXiaohong Zhang
Xiaohong Zhang
LLLirong Liu
Lirong Liu
YLYanhui Liu
Yanhui Liu
CZChunmei Zhang
Chunmei Zhang

4 July 2024 in Orphanet Journal of Rare Diseases
Verified
Journal Article
Open access
PDF file
WWWei Wang
Wei Wang
TYTing Yang
Ting Yang
QHQinghua Huang
Qinghua Huang
Purpose: To evaluate the available evidence regarding the quality of life (QoL) in patients with acromegaly, by synthesizing the psychosocial factors of QoL, QoL measures, and complementary interventions targeting QoL. Methods: A scoping review was conducted using the PRISMA-ScR guideline. We searched six English databases (PubMed, Embase, CINAHL, Scopus, Web of Science, and the Cochrane Library) from the inception to August 21, 2023. We included observational studies involving psychosocial factors and complementary interventions targeting QoL (concept) in patients with acromegaly (population) in any setting (context). The design characteristics, psychosocial factors, measures, details of interventions, and outcomes of included studies were described in detail. Results: Twenty-one studies were identified, including sixteen cross-sectional studies and five interventional studies. Ten categories of psychosocial factors that are associated with QoL in acromegaly. Depression and anxiety were the most frequent psychosocial factors. Seven different validated QoL measures were used. AcroQoL was the most common measure. Two categories of complementary interventions targeting QoL were identified including psychological and exercise interventions. Conclusions: Our scoping review provides a reasonably clear picture of the current research status of QoL in acromegaly. However, this review also highlights the need to deepen understanding of QoL and psychosocial factors in the future, as well as conduct longitudinal research and qualitative research to clarify the changing trends of psychosocial factors and specific experiences of patients. Further, more potential clinical complementary interventions are needed to improve QoL for patients with acromegaly.

1 December 2007 in Journal of the Neurological Sciences
Verified
Journal Article
Closed access
JMJianting Miao
Jianting Miao
HLHongzeng Li
Hongzeng Li
HLHong Lin
Hong Lin
CSChangjun Su
Changjun Su
YLYu Liu
Yu Liu
ZLZhuyi Li
Zhuyi Li

6 November 2025 in Frontiers in Aging
Verified
Journal Article
Open access
PDF file
HYHongyan Yang
Hongyan Yang
TYTing Yang
Ting Yang
HWHui Wei
Hui Wei
Background: Stroke-related sarcopenia has attracted increasing attention, and the prevalence is increasing. However, the influencing factors and clinical outcomes are still not well reported in the literature, and existing studies are heterogeneous in terms of study design, outcomes, and means of outcome assessment. We conducted this scoping review to map and summarize the evidence in the rapidly growing field of stroke-related sarcopenia, and guide future research directions. Purpose: To synthesize the influencing factors and clinical outcomes of stroke-related sarcopenia. Methods: The scoping review process followed the methodological framework of Arksey and O’Malley and was reported using the PRISMA-ScR guideline. Six English databases (PubMed, Embase, CINAHL, Scopus, Web of Science, and the Cochrane Library) were searched from the inception to 13 August 2024, and updated on 5 October 2025. We included studies involving influencing factors and clinical outcomes (concept) of stroke-related sarcopenia (population) in any setting (context). Results: Twenty-six studies were identified, including six cross-sectional and twenty cohort studies. Forty influencing factors were extracted and integrated into five categories, including demographic, disease, stroke-related, behavioral, and biomarker factors. Stroke-related sarcopenia can cause impaired motor, swallowing, neurological, and psychological function and lead to increased recurrence, readmission, and mortality. Conclusion: Our scoping review shows that stroke-related sarcopenia depends on multiple factors and has widespread effects. Understanding these influencing factors and clinical outcomes can help health professionals to intervene and manage stroke-related sarcopenia. However, heterogeneity in the details of the included studies made it difficult to undertake quantitative summaries across studies, more high-quality, multicenter studies should be conducted in the future to provide consistent evidence to guide clinical practice.